← Back to Search

Physiotherapist-Led Care for Osteoarthritis

N/A
Recruiting
Led By Jordan Miller, PhD
Research Sponsored by Jordan Miller, PT, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 9, and 12 months follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates if a new physiotherapist-led care model for hip & knee pain can help people & health systems in Canada.

Who is the study for?
This trial is for adults over 18 who want to see a primary care provider because of hip or knee pain. They must be able to understand, read, and write English. People with cancer or neurodegenerative diseases causing the pain, or those with post-arthroplasty (joint replacement) pain cannot join.
What is being tested?
The study is testing a new way of treating hip and knee pain where physiotherapists lead the care instead of doctors. It's set up as a pilot test in Canada where groups are randomly chosen to either try this new model or stick with the usual doctor-led approach.
What are the potential side effects?
Since this trial involves non-drug interventions like changes in how care is provided, typical medication side effects aren't expected. However, there might be risks associated with different physical therapy techniques used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 9, and 12 months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 9, and 12 months follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assessment Procedures
PT Treatment Fidelity
Participant Recruitment Rate
+1 more
Secondary study objectives
Adverse Events
Assistance Needed
Catastrophic Thinking
+28 more
Other study objectives
Baseline Characteristics
Chronicity of Pain
Comorbidities
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physiotherapist-led primary care model for hip and knee painExperimental Treatment1 Intervention
The index intervention will incorporate a PT within the primary care team and make them available at the first point of contact for people with hip or knee pain. There will be 4 key components of this intervention: 1) Initial assessment and screening; 2) Brief individualized intervention at first visit; 3) Health services navigation; 4) Providing additional PT care for people with an unmet need (e.g., no insurance coverage for PT).
Group II: Usual physician-led primary care model for hip and knee painActive Control1 Intervention
Participants will be seen by a primary care physician or a nurse practitioner, depending on the current practice at the clinic. Participants in both groups will be permitted to seek additional care outside of the primary care clinic.

Find a Location

Who is running the clinical trial?

Jordan Miller, PT, PhDLead Sponsor
2 Previous Clinical Trials
1,605 Total Patients Enrolled
The Arthritis Society, CanadaOTHER
26 Previous Clinical Trials
9,505 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,810 Total Patients Enrolled

Media Library

Physiotherapist-led primary care model for hip and knee pain Clinical Trial Eligibility Overview. Trial Name: NCT05736133 — N/A
Hip Osteoarthritis Research Study Groups: Usual physician-led primary care model for hip and knee pain, Physiotherapist-led primary care model for hip and knee pain
Hip Osteoarthritis Clinical Trial 2023: Physiotherapist-led primary care model for hip and knee pain Highlights & Side Effects. Trial Name: NCT05736133 — N/A
Physiotherapist-led primary care model for hip and knee pain 2023 Treatment Timeline for Medical Study. Trial Name: NCT05736133 — N/A
~33 spots leftby Feb 2025